Free tool
Diagnostics stocks
We cover 9 companies grouped under the Diagnostics theme. The median market value in the group is $307.41M. Across the group, the median move over the past trading day is +0.20%. Price change over the past year runs from −37.3% to +131.2% across the middle 80 percent of the group, with a median of +21.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
9 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $180.64M | Small cap | +21.78% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.